Volume 67 Received 8 December 2010 | ||||||||||
| ||||||||||
aX-ray Crystallography Unit, School of Physics, Universiti Sains Malaysia, 11800 USM, Penang, Malaysia, and bOrganic Chemistry Division, School of Advanced Sciences, VIT University, Vellore 632 014, India
Correspondence e-mail: hkfun@usm.my
The asymmetric unit of the title compound, C10H10N2O, contains two crystallographically independent molecules with similar geometries, which exist in the keto form. The C=O bond lengths are 1.2878 (12) Å in molecule A and 1.2890 (12) Å in molecule B, indicating that the compound undergoes enol-to-keto tautomerism during the crystallization process. In molecule A, the pyrazole ring is approximately planar [maximum deviation = 0.007 (1) Å] and forms a dihedral angle of 36.67 (6)° with the attached phenyl ring. In molecule B, the dihedral angle formed between the pyrazole ring [maximum deviation = 0.017 (1) Å] and the phenyl ring is 41.19 (6)°. In the crystal, intermolecular N-H
O hydrogen bonds link neighbouring molecules into dimers generating R22(8) ring motifs. These dimers are linked into ribbons along [101] via intermolecular N-H
O hydrogen bonds, forming R42(10) ring motifs.
For background to pyrazole derivatives and their antimicrobial activity, see: Ragavan et al. (2009
, 2010
). For bond-length data, see: Allen et al. (1987
). For the structure of the enol form of this molecule, see: Shahani et al. (2010
). For other related structures, see: Loh et al. (2010a
,b
,c
). For hydrogen-bond motifs, see: Bernstein et al. (1995
). For the stability of the temperature controller used in the data collection, see: Cosier & Glazer (1986
).
|
|
|
Data collection: APEX2 (Bruker, 2009
); cell refinement: SAINT (Bruker, 2009
); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008
); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ5074 ).
HKF and WSL thank Universiti Sains Malaysia (USM) for the Research University Grant (1001/PFIZIK/811160). WSL also thanks the Malaysian government and USM for the award of a Research Fellowship. VV is grateful to the DST-India for funding through the Young Scientist Scheme (Fast Track Proposal).
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Bruker (2009). APEXII, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Cosier, J. & Glazer, A. M. (1986). J. Appl. Cryst. 19, 105-107.
![[details]](../../../../../../j/graphics/details.gif)
Loh, W.-S., Fun, H.-K., Ragavan, R. V., Vijayakumar, V. & Sarveswari, S. (2010a). Acta Cryst. E66, o2925.
![[details]](../../../../../../e/graphics/details.gif)
Loh, W.-S., Fun, H.-K., Ragavan, R. V., Vijayakumar, V. & Venkatesh, M. (2010b). Acta Cryst. E66, o2563-o2564.
![[details]](../../../../../../e/graphics/details.gif)
Loh, W.-S., Fun, H.-K., Ragavan, R. V., Vijayakumar, V. & Venkatesh, M. (2010c). Acta Cryst. E66, o3050-o3051.
![[details]](../../../../../../e/graphics/details.gif)
Ragavan, R. V., Vijayakumar, V. & Sucheta Kumari, N. (2009). Eur. J. Med. Chem. 44, 3852-3857.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Ragavan, R. V., Vijayakumar, V. & Sucheta Kumari, N. (2010). Eur. J. Med. Chem. 45, 1173-1180.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Shahani, T., Fun, H.-K., Ragavan, R. V., Vijayakumar, V. & Sarveswari, S. (2010). Acta Cryst. E66, o1697-o1698.
![[details]](../../../../../../e/graphics/details.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)